Showing results (331-340 of 355) with videos related to

Sort By:
Pageof 36
The Biochemical Journal|March 6, 2014
Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitorsSeungil Han, Robert M Czerwinski, Nicole L Caspers, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for SchizophreniaAmy B Dounay, Marie Anderson, Bruce M Bechle, et al.
Hepatology Communications|March 7, 2023
Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter studyAmit G Singal, T Tara Ghaziani, Neil Mehta, et al.
Gastroenterology|November 9, 2024
Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in CirrhosisNaoto Fujiwara, Camden Lopez, Tracey L Marsh, et al.
Hepatology (Baltimore, Md.)|March 27, 2024
Quality measures in pre-liver transplant care by the Practice Metrics Committee of the American Association for the Study of Liver DiseasesMayur Brahmania, Alexander Kuo, Elliot B Tapper, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 8, 2026
Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic RegionsHidenori Toyoda, Yujin Hoshida, Neehar D Parikh, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Aminopyrazole Carboxamide Bruton's Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group TuningMark E Schnute, Stephen E Benoit, Ingrid P Buchler, et al.
Gastroenterology|August 3, 2019
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular CarcinomaAmit G Singal, Nicole E Rich, Neil Mehta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2023
Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular CarcinomaHidenori Toyoda, Mounika Kanneganti, Jonathan Melendez-Torres, et al.
Journal of Medicinal Chemistry|January 4, 2018
Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune DiseasesMichael L Vazquez, Neelu Kaila, Joseph W Strohbach, et al.
Pageof 36